E2F1 and nasopharyngeal carcinoma: Inhibition of E2F-1, possibly through suppression of ATM, blocked DDP-resistant NPC cells at the G1 phase with reduced cell proliferation, thereby reversing the resistance of human NPC cells to DDP.